(Q46288649)

English

Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.

scientific article published on 23 February 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/19233728

Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF. (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/19233728

author name string

Fernando Callera

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/19233728

Luciana Cavenaghi

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/19233728

Cláudio M T P de Melo

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/19233728

publication date

23 February 2009

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/19233728

Transfusion and Apheresis Science

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/19233728

40

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/19233728

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/19233728

91-95

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/19233728

G-CSF alone vs cyclophosphamide plus G-CSF in PBPC mobilization of patients with lymphoma: results depend on degree of previous pretreatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2009.01.015

7 January 2021

Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2009.01.015

7 January 2021

High-dose versus low-dose cyclophosphamide in combination with G-CSF for peripheral blood progenitor cell mobilization

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2009.01.015

7 January 2021

Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2009.01.015

7 January 2021

A combination of low-dose cyclophosphamide and colony-stimulating factors is more cost-effective than granulocyte-colony-stimulating factors alone in mobilizing peripheral blood stem and progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2009.01.015

7 January 2021

Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2009.01.015

7 January 2021

Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2009.01.015

7 January 2021

Low-dose or intermediate-dose cyclophosphamide plus granulocyte colony-stimulating factor for progenitor cell mobilisation in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2009.01.015

7 January 2021

Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphom

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2009.01.015

7 January 2021

Harvesting of autologous blood stem cells after a mobilising regimen with low-dose cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2009.01.015

7 January 2021

Peripheral blood progenitor cells versus bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2009.01.015

7 January 2021

Flow cytometric enumeration and immunophenotyping of hematopoietic stem and progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2009.01.015

7 January 2021

Effects of long-term storage at -90 degrees C of bone marrow and PBPC on cell recovery, viability, and clonogenic potential.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2009.01.015

7 January 2021

Comparison of peripheral blood progenitor cell yield from standard chemotherapy used in the treatment of lymphoid malignancies and high-dose cyclophosphamide: a retrospective review of 141 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2009.01.015

7 January 2021

Identifiers

10.1016/J.TRANSCI.2009.01.015

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/19233728

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/19233728

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46288649&oldid=1367168277"